Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion type Assertion NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_head.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion description "[Here, using a novel small-molecule BET bromodomain inhibitor, JQ1, and the EZH2 inhibitor, DZNep, we demonstrated that combined treatment of JQ1 and DZNep cooperatively disrupted MYC activation, resulting in a greater restoration of miR-26a expression and synergistically suppressed lymphoma growth and clonogenicity in aggressive lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_provenance.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion evidence source_evidence_literature NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_provenance.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion SIO_000772 23538750 NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_provenance.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion wasDerivedFrom befree-2016 NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_provenance.
- NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_assertion wasGeneratedBy ECO_0000203 NP1064691.RAia0pm_7KognMWn7wPJOkSBCZSpY6n_eSA1-5foLFPo0130_provenance.